Development and validation of a LC–MS/MS method for determination of bivalirudin in human plasma: Application to a clinical pharmacokinetic study
- 1 May 2010
- journal article
- clinical trial
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 52 (1) , 105-109
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Bivalirudin Provides Rapid, Effective, and Reliable Anticoagulation During Off-Pump Coronary Revascularization: Results of the ???EVOLUTION OFF??? TrialAnesthesia & Analgesia, 2006
- BivalirudinDrugs, 2005
- Liquid chromatography method for determination of bivalirudin in human plasma and urine using automated ortho-phthalaldehyde derivatization and fluorescence detectionJournal of Chromatography B, 2004
- Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass graftingThe American Journal of Cardiology, 2004
- Bivalirudin pharmacokinetics and pharmacodynamics: Effect of renal function, dose, and genderClinical Pharmacology & Therapeutics, 2002
- Novel fragmentation process of peptides by collision-induced decomposition in a tandem mass spectrometer: differentiation of leucine and isoleucineAnalytical Chemistry, 1987
- Letter to the editorsJournal of Mass Spectrometry, 1984